Trial Profile
A retrospective chart review of all organ transplant recipient patients who received Denosumab for treatment of osteoporosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 02 Jan 2017 New trial record